Squamous Cell Carcinoma of the Oropharynx Presenting with Distant Metastasis to the Ulna


Squamous cell carcinomas are the commonest malignancies of the head and neck. Metastases from stage III and stage IV tumors occur most commonly in the cervical lymph nodes. The incidence of distant metastases occurring from such advanced tumors is anywhere between 10% and 40%. Distant metastases occur most commonly to the lungs followed by the bone and liver. The bone metastasis occurs commonly in the axial skeleton. We report a rather unusual case of squamous cell carcinomas from the Head and Neck region in a 77-year-old male metastasizing to the ulna. This case is even more interesting because the presenting symptom was a pathological fracture of the ulna for which he had reported to the orthopedic department. The immunohistochemistry of the metastatic tumor had shown an unmistakable squamous cell carcinoma with positive cytokeratin elements within the tumor. He referred to the ENT department where he was diagnosed with T2N0M1 squamous cell carcinoma of the oropharynx. The patient was treated with internal fixation and bone cementing for the metastatic lesion, and primarily treated with chemoradiation.


Share and Cite:

P. Puthukudy and M. Feshan, "Squamous Cell Carcinoma of the Oropharynx Presenting with Distant Metastasis to the Ulna," International Journal of Otolaryngology and Head & Neck Surgery, Vol. 2 No. 6, 2013, pp. 240-244. doi: 10.4236/ijohns.2013.26050.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] C. W. Crile, “Carcinoma of the Jaws, Tongue, Cheek, and Lips,” Surgery Gynecology & Obstetrics, Vol. 36, 1923, pp. 159-184.
[2] J. C. Probert, R. W. Thompson and M. A. Bagshaw, “Patterns of Spread of Distant Metastasis in Head and Neck Cancer,” Cancer, Vol. 33, No. 1, 1974, pp. 127-133.
[3] D. S. Berger and C. H. Fletcher, “Distant Metastasis Following Local Control of Squamous Cell Carcinoma of the Nasopharynx, Tonsillar Fossa, and Base of Tongue,” Radiology, Vol. 100, 1971, pp. 141-143.
[4] M. R. Orlando, L. Robert and F. D. Gilbert, “An Analysis of Distant Metastases from Squamous Cell Carcinoma of the Upper Respiratory and Digestive Tracts,” Cancer, Vol. 40, No. 1, 1977, pp. 45-151.
[5] S. Marur and A. A. Forastiere, “Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment,” Mayo Clinic Proceedings, Vol. 83, No. 4, 2008, pp. 489-501.
[6] P. J. Bradley, “Management of Squamous Cell Carcinoma of the Oropharynx,” Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 8, No. 5, 2000, pp. 80-86.
[7] K. L. Robinson and G. J. Macfarlane, “Oropharyngeal Cancer Incidence and Mortality in Scotland: Are Rates Still Increasing?” Oral Oncology, Vol. 39, No. 1, 2003, pp. 31-36.
[8] S. Mak-Kregar, F. J. M. Hilgers, P. C. Levendag, J. J. Manni, H. Lubsen, J. L. Roodenburg, et al., “A Nationwide Study of the Epidemiology, Treatment and Survival of Oropharyngeal Carcinoma in the Netherlands,” European Archives of Oto-Rhino-Laryngology, Vol. 252, No. 3, 1995, pp. 133-138.
[9] J. S. Tobias, “Cancer of the Head and Neck,” British Medical Journal, Vol. 308, 1994, pp. 961-966.
[10] P. J. Donald, “Marijuana Smoking: Possible Cause of Head and Neck Cancer in Young Patients,” Otolaryngology and Head and Neck Surgery, Vol. 94, No. 4, 1986, pp. 517-521.
[11] M. Romanitan, A, Nasman, T. Ramqvist, H. Dahlstrand, L. Polykretis, P. Vogiatzis, et al., “Human Papillomavirus Frequency in Oral and Oropharyngeal Cancer in Greece,” Anticancer Research, Vol. 28, No. 4B, 2008, pp. 2077-2080.
[12] M. Pitchers and C. Martin, “Delay in Referral of Oropharyngeal Carcinoma to Secondary Care Correlates with a More Advanced Stage at Presentation, and Is Associated with Poorer Survival,” British Journal of Cancer, Vol. 94, No. 7, 2006, pp. 955-958.
[13] J. B. Patrick, “Oropharyngeal Tumors,” In: G. Michael, Ed., Scott-Brown’s Otorhinolaryngology, Head and Neck Surgery, 7th Edition, Hodder Arnold, London, 2008, pp. 2577-2597.
[14] W. J. Goodwin, “Distant Metastases from Oropharyngeal Cancerm,” Journal for Oto-Rhino-Laryngology and Its Related Specialties, Vol. 63, No. 4, 2001, pp. 222-223.
[15] C. R. Leemans, R. Tiwari, J. J. P. Nauta, I. van der Waal and G. B. Snow, “Regional Lymph Node Involvement and Its Significance in the Development of Distant Metastasis in Head and Neck Carcinoma,” Cancer, Vol. 71, No. 2, 1993, pp. 452-456.
[16] S. Kramer, V. A. Marcial, T. K. Pajak, C. J. MacLean and L. W. Davis, “Prognostic Factors for Loco/Regional Control and Metastases and the Impact on Survival,” International Journal of Radiation Oncology · Biology · Physics, Vol. 12, No. 4, 1986, pp. 573-578.
[17] R. J. Papack, “Distant Metastases from Head and Neck Cancer,” Cancer, Vol. 53, No. 2, 1984, pp. 342-345.
[18] G. F. Gowen and G. Desuto-Nagy, “The Incidence and Sites of Distant Metastasis in Head and Neck Carcinoma,” Surgery Gynecology & Obstetrics, Vol. 47, 1963, pp. 603-607.
[19] D. B. Remco, E. D. Elene, B. S. Gordon and R. L. Charles, “Screening for Distant Metastases in Patients with Head and Neck Cancer,” Laryngoscope, Vol. 110, No. 3, 2000, pp. 397-401.
[20] B. Vikram, E. W. Strong, J. P. Shah and R. Spiro, “Failure at Distant Sites Following Multi Modality Treatment for Advanced Head and Neck Cancer,” Head and Neck Surgery, Vol. 6, No. 3, 1984, pp. 730-733.
[21] M. L. Dennington, D. R. Carter and A. D. Meyers, “Distant Metastases in Head and Neck Epidermoid Carcinoma,” Laryngoscope, Vol. 90, No. 2, 1980, pp. 196-201.
[22] R. J. Black, J. L. Gluckman and D. A. Shumrick, “Screening for Distant Metastases in Head and Neck Cancer Patients,” Australian and New Zealand Journal of Surgery, Vol. 54, No. 6, 1984, pp. 527-530.
[23] H. C. Karen, F. Paul, W. Raymond and A. H. James, “Distant Metastases from Head and Neck Squamous Cell Carcinoma,” Laryngoscope, Vol. 104, No. 10, 1994, pp. 1199-1205.
[24] N. L. Higinbotham and R. C. Marcove, “The Management of Pathological Fractures,” Journal of Trauma, Vol. 5, No. 6, 1965, pp. 792-798.
[25] F. H. Sim, “Instructional Course Lectures: Metastatic Bone Disease,” In: Instructional Course Lectures, Vol. 49, American Academy of Orthopaedic Surgeons, Anaheim, 1999.
[26] L. B. Harrison, A. Ferlito, A. R. Shaha, P. J. Bradley and A. Rinaldo, “Current Philosophy on the Management of Cancer of the Base of Tongue,” Oral Oncology, Vol. 39, No. 2, 2003, pp. 101-105.
[27] W. Zhen, L. H. Karnell, H. T. Hoffman, G. F. Funk, J. M. Buatti and H. Menck, “The National Cancer Data Base Report on Squamous Cell Carcinoma of the Base of Tongue,” Head and Neck, Vol. 26, No. 8, 2004, pp. 660-674. http://dx.doi.org/10.1002/hed.20064
[28] K. Sundaram, J. Schwartz, G. Har-El and F. Lucente, “Carcinoma of the Oropharynx: Factors Affecting Outcome,” Laryngoscope, Vol. 115, No. 9, 2005, pp. 1536-1542.
[29] C. G. Gourin and J. T. Johnson, “Surgical Treatment of Squamous Cell Carcinoma of the Tongue,” Head and Neck, Vol. 23, No. 8, 2001, pp. 653-660.
[30] G. Calais, M. Alfonsi, E. Bardet, C. Sire, T. Germain, P. Bergerot, et al., “Randomized Trial of Radiation Therapy versus Concomitant Chemotherapy and Radiation Therapy for Advanced Stage Oropharynx Carcinoma,” Journal of National Cancer Institute, Vol. 91, No. 24, 1999, pp. 2081-2086. http://dx.doi.org/10.1093/jnci/91.24.2081
[31] U. Selek, A. S. Garden, W. H. Morrison, A. K. El-Naggar, D. I. Rosenthal and K. K. Ang, “Radiation Therapy for Early Staged Carcinoma of the Oropharynx,” International Journal of Radiation Oncology, Biology, Physics, Vol. 59, No. 3, 2004, pp. 743-751.
[32] L. B. Harrison, “Applications of Brachytherapy in Head and Neck Cancer,” Seminars in Surgical Oncology, Vol. 13, No. 3, 1997, pp. 177-184.
[33] D. M. Kaylie, K. R. Stevens, M. Y. Kang, J. I. Cohen, M. K. Wax and P. E. Anderson, “External Beam Radiation Followed by Planned Neck Dissection and Brachytherapy for Base of Tongue Squamous Cell Carcinoma,” Laryngoscope, Vol. 110, No. 10, 2000, pp. 1633-1636.
[34] A. S. Denittis, M. Machtay, D. I. Rosenthal, N. J. Sanfillippo, J. H. Lee, S. Goldfeder, et al., “Advanced Oropharyngeal Carcinoma Treated with Surgery and Radiotherapy: Oncologic Outcome and Functional Assessment,” American Journal of Otolaryngology, Vol. 22, No. 5, 2001, pp. 329-335.
[35] A. Y. Chen, N. Schrag, Y. Hao, A. Stewart and E. Ward, “Changes in Treatment of Advanced Oropharyngeal Cancer. 1985-2001,” Laryngoscope, Vol. 1, No. 17, 2007, pp. 16-21.
[36] J. P. Pignon, N. Syz, M. Posner, R. Olivares, L. Le Lann, A. Yver, et al., “Adjusting for Patient Selection Suggests the Addition of Docetaxel to 5-Fluorouracil-Cisplatin Induction Therapy May Offer Survival Benefit in Squamous Cell Cancer of the Head and Neck,” Anticancer Drugs, Vol. 15, No. 4, 2004, pp. 331-340.
[37] M. R. Posner, D. M. Hershock, C. R. Blajman, E. Mickiewicz, E. Winquist, V. Gorbounova, et al., “Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Cancer,” New England Journal of Medicine, Vol. 354, No. 6, 2006, pp. 567-578.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.